CREBBP and diffuse intrinsic pontine glioma: The synergistic cytotoxic effect of the BET inhibitor JQ-1 and the transcriptional activator CREB-binding protein (CBP), which recruiats bromodomain (BRD) proteins, showed to be effective as a therapy for diffuse intrinsic pontine glioma [76].